I think like most people I am still a little undecided about the new vaccine and whether it will be better than the single ones :? I do think I understand how it works though. My honours project was on rabbit vaccinations and I read quite a lot about the vaccines and a little on the research into creating a combined one. I don't want to patronise anyone but I can maybe help those who don't fully understand. It was almost two years ago that I did my study so I may not remember everything so if anyone who is more knowledgeable can correct or confirm this then please do
Viruses have proteins on the surface which are specific to each type and strain of virus. The proteins act as a kind of signal to the immune system which allows them to recognise a particular virus and produce antibodies which bind to them. The new vaccine uses just one strain of the myxoma virus. This specific strain has been engineered to have a gene that makes it produce one of the VHD virus proteins as well as producing its own proteins. What this means is that the immune system will only be reacting to a single virus, just as it does for the other single vaccines, but it will produce antibodies for a vhd protein as well as the myxoma ones and will create a ‘memory’ so that it will recognise any of these proteins in the future. Most viruses have several proteins on their surface so this is no different. If the bun is faced with either the myxoma or VHD virus once vaccinated, it will be able to recognise the proteins on the surface of both of them and can mount an immune response more quickly in order to prevent illness. This ‘memory’ of the proteins will only last a specific time which is why boosters are needed.
From what I can gather, and someone correct me if I am wrong, the reason there is a difference in reactions/tolerance of the single vaccines is because the myxo vaccine is a live attenuated vaccine and the VHD ones are inactive vaccines. Live virus vaccines trigger the immune system naturally, whereas inactive ones don’t. They need to add something called an adjuvant to inactivated vaccines. This is a chemical that triggers the immune response, the virus itself can’t do this because it is dead. The adjuvant has to produce a strong enough reaction to make the immune system respond to the dead virus in the same way as it would a live one, but I believe it is possible that this is what can also cause the adverse reactions that affect some rabbits. Because the new vaccine is live, it does not contain an adjuvant and so won’t necessarily cause the same problems as the single VHD vaccines. The combined one should work similarly to the old myxo vaccine, although it does depend on how the immune system responds to the new vaccine strain.
I don't think that this vaccine should be avoided just on the basis that a rabbit has reacted badly to a VHD vaccine in the past, but I still think we should wait and see how different rabbits cope with the new vaccine before we can make an informed decision. If some rabbits react to the new vaccine but have previously had the old myxo vaccine with no ill effects then that is a good basis for arguing against its withdrawal.